Natixis Advisors, L.P. Conmed Corp Transaction History
Natixis Advisors, L.P.
- $53.5 Billion
- Q4 2024
A detailed history of Natixis Advisors, L.P. transactions in Conmed Corp stock. As of the latest transaction made, Natixis Advisors, L.P. holds 122,550 shares of CNMD stock, worth $7.74 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
122,550
Previous 110,909
10.5%
Holding current value
$7.74 Million
Previous $7.98 Million
5.14%
% of portfolio
0.02%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding CNMD
# of Institutions
300Shares Held
36.2MCall Options Held
144KPut Options Held
4.9K-
Black Rock Inc. New York, NY4.99MShares$315 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.57MShares$226 Million0.0% of portfolio
-
Earnest Partners LLC Atlanta, GA2.81MShares$177 Million0.9% of portfolio
-
Capital Research Global Investors Los Angeles, CA1.58MShares$99.6 Million0.02% of portfolio
-
State Street Corp Boston, MA1.36MShares$85.8 Million0.0% of portfolio
About CONMED Corp
- Ticker CNMD
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 30,482,400
- Market Cap $1.92B
- Description
- CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...